These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 7155939

  • 21. Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part I).
    Ponto LL, Schoenwald RD.
    Clin Pharmacokinet; 1990 May; 18(5):381-408. PubMed ID: 2185908
    [Abstract] [Full Text] [Related]

  • 22. The pharmacokinetics and pharmacodynamics of furosemide in anesthetized dogs with normal and experimentally decreased renal function.
    Miyazaki H, Hirai J, Taneike T.
    Nihon Juigaku Zasshi; 1990 Apr; 52(2):265-73. PubMed ID: 2348592
    [Abstract] [Full Text] [Related]

  • 23. Diuretic effect of slow-release furosemide in elderly patients.
    Vermeulen A, Chadha DR.
    Eur J Clin Pharmacol; 1983 Apr; 24(4):449-51. PubMed ID: 6861859
    [Abstract] [Full Text] [Related]

  • 24. The natriuretic effect addition of quinethazone and furosemide in congestive heart failure. A permutation trial test.
    Olesen KH.
    Acta Med Scand; 1971 Sep; 190(3):229-32. PubMed ID: 4941226
    [No Abstract] [Full Text] [Related]

  • 25. Pharmacokinetics of furosemide in patients with congestive heart failure.
    Greither A, Goldman S, Edelen JS, Benet LZ, Cohn K.
    Pharmacology; 1979 Sep; 19(3):121-31. PubMed ID: 523503
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Increased nonrenal clearance and increased diuretic efficiency of furosemide in cystic fibrosis.
    Alván G, Beermann B, Hjelte L, Lind M, Lindholm A, Strandvik B.
    Clin Pharmacol Ther; 1988 Oct; 44(4):436-41. PubMed ID: 3168395
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Unconventional treatment of severe heart failure in the elderly].
    Fidelman Z, Korshun Z.
    Harefuah; 2000 Mar 01; 138(5):354-6, 424. PubMed ID: 10883130
    [Abstract] [Full Text] [Related]

  • 33. The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance.
    Givertz MM, Massie BM, Fields TK, Pearson LL, Dittrich HC, CKI-201 and CKI-202 Investigators.
    J Am Coll Cardiol; 2007 Oct 16; 50(16):1551-60. PubMed ID: 17936154
    [Abstract] [Full Text] [Related]

  • 34. Effect of torsemide and furosemide on clinical, laboratory, radiographic and quality of life variables in dogs with heart failure secondary to mitral valve disease.
    Peddle GD, Singletary GE, Reynolds CA, Trafny DJ, Machen MC, Oyama MA.
    J Vet Cardiol; 2012 Mar 16; 14(1):253-9. PubMed ID: 22364690
    [Abstract] [Full Text] [Related]

  • 35. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G, Di Pasquale P, Parrinello G, Cardinale A, Scandurra A, Follone G, Argano C, Tuttolomondo A, Paterna S.
    Am Heart J; 2003 Mar 16; 145(3):459-66. PubMed ID: 12660669
    [Abstract] [Full Text] [Related]

  • 36. [Diuretics in the neonatal period].
    Guignard JP, Dubourg L, Gouyon JB.
    Rev Med Suisse Romande; 1995 Aug 16; 115(8):583-90. PubMed ID: 7569538
    [Abstract] [Full Text] [Related]

  • 37. Additive diuretic effect of S-8666 during furosemide-induced diuresis in rats.
    Shimizu T, Itoh T, Nakamura M.
    J Pharmacol Exp Ther; 1989 Aug 16; 250(2):659-66. PubMed ID: 2760848
    [Abstract] [Full Text] [Related]

  • 38. The supra-additive natriuretic effect addition of quinethazone or bendroflumethiazide during long-term treatment with furosemide and spironolactone. Permutation trial tests in patients with congestive heart failure.
    Olesen KH, Sigurd B.
    Acta Med Scand; 1971 Sep 16; 190(3):233-40. PubMed ID: 4941227
    [No Abstract] [Full Text] [Related]

  • 39. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation].
    De Vecchis R, Pucciarelli G, Nocerino L, Cocozza M, Setaro A, Torre G, Imperatore F.
    Minerva Cardioangiol; 1998 May 16; 46(5):163-74. PubMed ID: 9842199
    [Abstract] [Full Text] [Related]

  • 40. Combination of furosemide and metolazone in the treatment of severe congestive heart failure.
    Grosskopf I, Rabinovitz M, Rosenfeld JB.
    Isr J Med Sci; 1986 Nov 16; 22(11):787-90. PubMed ID: 3793436
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.